Loading organizations...
Loading organizations...
Montreux Equity Partners is a private investment firm dedicated to building the leading healthcare companies of tomorrow.
Key people at Montreux Equity Partners.
Montreux Equity Partners is a growth equity firm that provides capital to commercial-stage companies. The firm focuses on identifying and investing in high-growth enterprises within the healthcare and financial technology sectors, supporting businesses that demonstrate category-leading products, technologies, and services. Their investment approach targets established companies poised for accelerated expansion and market penetration.
The firm was founded in 1993 by Daniel Turner, who established Montreux Equity Partners with a vision to capitalize on emerging opportunities in specific growth markets. Drawing on his extensive experience as an entrepreneur, operating manager, and venture capitalist, Turner recognized the critical need for strategic growth capital to scale promising companies effectively. This foundational insight shaped the firm's long-term investment philosophy.
Montreux Equity Partners serves companies operating within the healthcare and financial technology landscapes. The firm's overarching mission is to accelerate the scale and development of these portfolio companies, guiding them through crucial growth phases. They aim to advance innovation and solidify market leadership for their investments, fostering significant long-term value in dynamic industries.
Key people at Montreux Equity Partners.
Montreux Equity Partners is a private investment firm focused on building the leading healthcare companies of tomorrow. Founded in 1993, Montreux specializes in growth capital investments in high-growth, commercial-stage companies that offer category-leading products, technologies, and services—primarily in healthcare and health IT. The firm’s mission is to accelerate the scale of innovative companies that are advancing health, with a philosophy centered on active partnership, deep sector expertise, and strategic support. Montreux typically invests $10–20 million per company, targeting businesses with $5–50 million in annual revenue. Its impact on the startup ecosystem is marked by a track record of over 80 investments and more than 20 exits, including notable successes such as MINDBODY, Glaukos, Tobira Therapeutics, and MAKO Surgical.
Montreux Equity Partners was founded in 1993 by Daniel Turner, establishing itself as a venture capital firm with a focus on healthcare innovation. Over the years, the firm evolved into Montreux Growth Partners, sharpening its focus on growth-stage investments in commercialized healthcare and fintech companies. The firm’s leadership team brings together complementary expertise in operations, finance, and sector-specific knowledge, allowing Montreux to provide not just capital but also hands-on guidance to its portfolio companies. Early investments in companies like Tobira Therapeutics and MAKO Surgical helped solidify Montreux’s reputation as a trusted partner for scaling healthcare innovators.
Montreux Equity Partners is riding the wave of digital transformation in healthcare, a sector experiencing rapid innovation in areas like patient engagement, financial management, and electronic health records. The timing is critical as healthcare systems seek scalable solutions to improve efficiency, patient outcomes, and financial sustainability. Montreux’s focus on growth-stage companies positions it at the intersection of innovation and commercialization, helping to bridge the gap between promising technologies and widespread adoption. By supporting companies that modernize healthcare delivery, Montreux plays a key role in shaping the future of the industry.
Looking ahead, Montreux Equity Partners is well-positioned to continue driving growth in the healthcare and health IT sectors. As demand for digital health solutions accelerates, Montreux’s expertise and network will be increasingly valuable to entrepreneurs seeking to scale. The firm’s influence is likely to expand as it backs companies at the forefront of trends like telehealth, AI-driven diagnostics, and patient-centric care models. Montreux’s legacy of building leading healthcare companies will endure, making it a cornerstone of the innovation ecosystem for years to come.
